Product Name: Human SLAMF7 Antibody (Elotuzumab, Research Use)
Catalog Number: NBR-0084
Target Name: SLAMF7
Trade Name: Elotuzumab
Antibody Drug Description: Elotuzumab, sold under the brand name Empliciti, is a humanized IgG1 monoclonal antibody medication used in combination with lenalidomide and dexamethasone, for adults that have received 1 to 3 prior therapies for the treatment of multiple myeloma. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: SLAMF7
Synonyms: CRACC; CS1; CD319; 19A
Target Description: Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo-or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response.
Ensembl: ENSG00000026751
Uniprot:  Q9NQ25